Serum soluble mediator signatures of lupus nephritis: histological features and response to treatment

By afschroeder • October 6, 2025

Fava A, Wagner CA, Guthridge CJ, Macwana S, DeJager W, Munroe ME, Izmirly P, Belmont HM, Diamond B, Davidson A, Utz PJ, Weisman MH, Carlucci PM, Dall'Era M, Kalunian K, Putterman C, Anolik J, Barnas JL, Wofsy D, Kamen D, Furie RA, Rao DA; Accelerating Medicines Partnership (AMP) RA/SLE Network; Petri M, Guthridge JM, Buyon J, James JA. Serum soluble mediator signatures of lupus nephritis: histological features and response to treatment. Arthritis Care Res (Hoboken). 2025 Oct 6. doi: 10.1002/acr.25652. Epub ahead of print. PMID: 41048053.

Tags: Cedars Sinai DoM, Publications, Rheumatology

Bioactive Lipids of Cardiorespiratory Fitness Insights From Exercise Models in Humans, Mice, and Burmese Pythons

Guseh JS, Roshandelpoor A, Alotaibi M, Zarbafian S, Lau ES, Kuznetsov A, Rosenzweig A, Saeidi N, Choudhary A, Jain M, Cheng S, Lewis GD, Ho[...]

Improved plaque composition from intensive medical treatment in women with angina and non-obstructive coronary disease

Lenell J, Flores Tomasino G, Han D, Wolny R, Park C, Grodecki K, Kwiecinski J, Xing E, Manral N, Asebiomo F, Goyal D, Calsavara VF,[...]

Mechanical Thrombectomy Versus Anticoagulation Alone in Intermediate-High Risk PE: Improved Functional 90-Day Outcomes in STORM-PE RCT

Rosovsky RP, Konstantinides SV, Weinberg I, Dohad SY, Rosol Z, Stępniewski J, Moriarty JM, Parikh SA, Holden A, Channick RN, McDonald B, Nagarsheth KH, Matusov[...]